Summary:
A double blind, placebo controlled evaluation of the safety and efficacy of Vilazodone in adolescent patients with Major Depressive disorder.
Qualified Participants Must:
• Be between 12 and 17 years of age
•
Currently be diagnosed with Depression or feeling depressed at least the past 6 weeks
Qualified Participants May Receive:
Free medical evaluation, free study medication and compensation for time and travel.